These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29952031)

  • 1. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
    Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
    Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment.
    Ibis K; Saglam S; Saglam EK; Firat P; Yilmazbayhan D; Toker A; Ozkan B; Hancer VS; Buyukdogan M; Disci R; Pilanci KN
    Pathol Res Pract; 2018 Sep; 214(9):1291-1296. PubMed ID: 30029935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
    Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
    Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
    Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic marker analysis in pediatric intracranial ependymomas.
    McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
    J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.
    Kyndi M; Sørensen FB; Knudsen H; Alsner J; Overgaard M; Nielsen HM; Overgaard J;
    Breast Cancer Res; 2008; 10(2):R24. PubMed ID: 18355402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.
    Liao SY; Darcy KM; Randall LM; Tian C; Monk BJ; Burger RA; Fruehauf JP; Peters WA; Stock RJ; Stanbridge EJ
    Gynecol Oncol; 2010 Mar; 116(3):452-8. PubMed ID: 19913895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
    Kim JY; Lee SH; An S; Kim SJ; Sung YN; Song KB; Hwang DW; Kim SC; Hong SM
    Virchows Arch; 2018 May; 472(5):739-748. PubMed ID: 29666945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
    Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
    World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
    Shieh LT; Guo HR; Ho CH; Lin LC; Chang CH; Ho SY
    PLoS One; 2020; 15(5):e0233188. PubMed ID: 32413077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
    Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
    Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
    J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.